Sharon Bio-Medicine Ltd. Company History and Annual Growth Details

1995: Current Mnagement took over and started manufacturing of Pharma

intermediates

1997: Started manufacturing API's - launched its first drug Trimetazidine di

hydrochloride

2000: Came withpublic offering of 25% Shares. Issue was oversubscribed

by 3.85 times.

2000: Set up a R&D block to out Process synthesis for API's &

Intermediates.

Jan 2005: Hon, Finance Minister of India Mr.P.Chidambaram put our

company on the INDO NEXT at the BOMBAY STOCK EXCHANGE.

Jan 2005: Company was awarded with the ISO 9001-2000 accreditation by

BVQI - UKAS & BVQI - ANAB

Mid 2005: Commissioning of a State of Art Formulation Unit for Oral Solid

Dosages was started, Estimated cost of the project over 8 m USD

2006: Currently one of the leading manufacturers of Trimetazidine Di HCL

, Ketoconazole and Pantoprazole Sodium in the country,besides catering to

a widerange of drug intermedites for the Anti fungal & Anti Ulcer categories

to name a few.

The services provided by the company are contract research and

manufacturers, technology transfers and project consultancy.

2009

- Company name has been changed from Sharon Pharma Chem Ltd to Sharon Bio-Medicine Ltd .

2010

- Sharon Bio-Medicine Ltd has appointed Mr. Drunal Shah and Mr. Harish Palecanda, as Directors of the Company, w.e.f. December 31, 2009.

2011

- Sharon Bio-Medicine Ltd has signed Memorandum of Understanding on February 24, 2011 between Sharon Bio-Medicine Ltd. and The State - Joint Stock Concern "Uzpharmsanoat".

- Sharon Bio-Medicine Ltd "Approval of Good Laboratory Practices by Ministry of Science & Technology, New Delhi for Toxicology Unit"

2012

- Sharon Bio-Medicine Ltd Board recommends Dividend dividend @ Rs. 1.80 per share subject to approval of shareholders at the Annual General Meeting.

- Sharon Bio-Medicine Ltd receives Rs 690 lakh subsidy from Ministry of Science & Technology

2013

- Sharon Bio-Medicine has setting up a Genotoxicity Laboratory at Taloja near Navi Mumbai.
-Sharon has recommended dividend of Rs. 1.50/- per share.
- Mr. Madhav Manohar has been appointed as Additional Director w.e.f. September 01, 2013.

2014

-Sharon has recommended dividend @18%.
-Sharon Bio-Medicine bags GLP Certificate for Raigarh unit
-Sharon Bio-Medicine has announces bonus in the ratio of 1:1
-Sharon Bio-Medicine has splits its face value from Rs 10/- to 2/-

2015
-Sharon Bio-Medicine Ltd have received the certification for the approval of Good Manufacturing Practices (GMP) for both, Capsules and Tablets from United Kingdom - Medical & Health Care Product Regulatory Agency (UKMHRA) for its expanded area of Formulation and Tablets unit
-Sharon Bio-Medicine gets EIR from USFDA for Dehradun mfg unit

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article